{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:20:31Z","timestamp":1783128031637,"version":"3.54.6"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.anndiagpath.2019.151405","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T11:57:38Z","timestamp":1573732658000},"page":"151405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Myeloid neoplasm with eosinophilia and BCR-JAK2\/t(9;22)(p24;q11.2) morphologically mimicking chronic myeloid leukemia"],"prefix":"10.1016","volume":"44","author":[{"given":"Beenu","family":"Thakral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Muzzafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.anndiagpath.2019.151405_bb0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2019.151405_bb0010","series-title":"Myeloid\/lymphoid neoplasms with eosinophilia and rearrangements of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2","author":"Bain","year":"2017"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151405_bb0015","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151405_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01697986","article-title":"Hypereosinophilic syndrome in Hodgkin\u2019s disease with increased granulocyte-macrophage colony-stimulating factor","volume":"71","author":"Endo","year":"1995","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2019.151405_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","article-title":"8p11 myeloproliferative syndrome: a review","volume":"41","author":"Jackson","year":"2010","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151405_bb0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/030089169107700616","article-title":"A case of T-cell lymphoma accompanying marked eosinophilia, chronic eosinophilic pneumonia and eosinophilic pleural effusion. A case report","volume":"77","author":"Kawasaki","year":"1991","journal-title":"Tumori"},{"issue":"12","key":"10.1016\/j.anndiagpath.2019.151405_bb0035","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.3109\/10428194.2016.1170827","article-title":"Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology","volume":"57","author":"Loghavi","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.anndiagpath.2019.151405_bb0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/bjh.12963","article-title":"Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?","volume":"166","author":"Bain","year":"2014","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2019.151405_bb0045","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ajh.24196","article-title":"World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gotlib","year":"2015","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151405_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/gcc.20235","article-title":"A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia","volume":"44","author":"Griesinger","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.anndiagpath.2019.151405_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cancergen.2016.03.002","article-title":"BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia","volume":"209","author":"He","year":"2016","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1016\/j.anndiagpath.2019.151405_bb0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/AJCPMORR5Z2IKCEM","article-title":"Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1","volume":"144","author":"Vega","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2019.151405_bb0065","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2016.75","article-title":"Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151405_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00277-014-2221-y","article-title":"Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes","volume":"94","author":"Schwaab","year":"2015","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2019.151405_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cancergencyto.2008.02.005","article-title":"A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia","volume":"183","author":"Cirmena","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2019.151405_bb0080","series-title":"Myeloproliferative and \u201cOverlap\u201d Myelodysplastic\/Myeloproliferative Neoplasms","author":"Thakral","year":"2018"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291341930320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291341930320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:31:35Z","timestamp":1761078695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109291341930320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":16,"alternative-id":["S109291341930320X"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151405","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid neoplasm with eosinophilia and BCR-JAK2\/t(9;22)(p24;q11.2) morphologically mimicking chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151405"}}